Evidence map›Paper›PMID 39361015›Full record

Observational studyJournal of acquired immune deficiency syndromes (1999)2025

Quality of Life in People With HIV at the End of Life: Preliminary Results From the Last Gift Observational Cohort Study.

Brahm Coler, Gordon Honerkamp Smith, Anish K Arora, Adam Wells, Stephanie Solso, Cheryl Dullano, Susanna Concha-Garcia, Eddie Hill, Patricia K Riggs, Anastasia Korolkova and 6 more

Abstract readObservational Study
In one paragraph

Observational study in Journal of acquired immune deficiency syndromes (1999), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Brahm ColerSchool of Medicine, University of Washington, Seattle, WA.
Gordon Honerkamp SmithDivision of Infectious Diseases and Global Public Health, Department of Medicine, University of California San Diego, San Diego, CA.
Anish K AroraCanadian Institute of Health Research Strategy for Patient-Oriented Research Mentorship Chair in Innovative Clinical Trials, Montreal, Quebec, Canada.
Adam WellsSchool of Medicine, University of Washington, Seattle, WA.
Stephanie SolsoAntiViral Research Center (AVRC), University of California San Diego (UCSD), San Diego, CA.
Cheryl DullanoAntiViral Research Center (AVRC), University of California San Diego (UCSD), San Diego, CA.
Susanna Concha-GarciaAntiViral Research Center (AVRC), University of California San Diego (UCSD), San Diego, CA.
Eddie HillDivision of Infectious Diseases and Global Public Health, Department of Medicine, University of California San Diego, San Diego, CA.
Patricia K RiggsDivision of Infectious Diseases and Global Public Health, Department of Medicine, University of California San Diego, San Diego, CA.
Anastasia KorolkovaDivision of Infectious Diseases and Global Public Health, Department of Medicine, University of California San Diego, San Diego, CA.
Robert DeissDivision of Infectious Diseases and Global Public Health, Department of Medicine, University of California San Diego, San Diego, CA.
Davey SmithDivision of Infectious Diseases and Global Public Health, Department of Medicine, University of California San Diego, San Diego, CA.
Erin E SundermannDivision of Psychiatry, Department of Medicine, University of California San Diego, San Diego, CA.
Sara GianellaDivision of Infectious Diseases and Global Public Health, Department of Medicine, University of California San Diego, San Diego, CA.
Antoine ChaillonDivision of Infectious Diseases and Global Public Health, Department of Medicine, University of California San Diego, San Diego, CA.
Karine DubéDivision of Infectious Diseases and Global Public Health, Department of Medicine, University of California San Diego, San Diego, CA.ORCID 0000-0003-3458-1539

Funding

VirologyP30AI036214 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI SUSAN JANET LITTLE · 1994 to 2026
$78.4M
BEAT-HIV: Delaney Collaboratory to Cure HIV-1 Infection by Combination ImmunotherapyUM1AI164570 · NIAID · WISTAR INSTITUTE · PI Luis J Montaner, James L. Riley · 2021 to 2026
$34.7M
HOPE - HIV Obstruction by Programmed EpigeneticsUM1AI164559 · NIAID · J. DAVID GLADSTONE INSTITUTES · PI Lishomwa C Ndhlovu, Melanie Maria Ott · 2021 to 2026
$32.2M
First-in-human study of two anti-SARS CoV-2 antibodies in health volunteersUM1AI126620 · NIAID · WISTAR INSTITUTE · PI MONTANER, LUIS J, RILEY, JAMES L. · 2016 to 2021
$24.5M
California NeuroAIDS Tissue NetworkU24MH100928 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ACHIM, CRISTIAN L, MOORE, DAVID J · 2013 to 2023
$13.9M
Project-004P01AI169609 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI David Mitchell Smith · 2022 to 2026
$10.6M
Revealing Reservoirs during Rebound (R3)P01AI131385 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI DEGRUTTOLA, VICTOR GERARD · 2017 to 2021
$8.7M
National Institute of Allergy and Infectious Diseases UM1AI126620NIAID NIH HHS P01 AI131385NIAID NIH HHS P01 AI169609NIAID NIH HHS P30 AI036214NIAID NIH HHS UM1 AI126620NIAID NIH HHS UM1 AI164559NIAID NIH HHS UM1 AI164570NIMH NIH HHS U24 MH100928
6 · The paper itself

Abstract

backgroundAs people living with HIV (PWH) age, they face new challenges that can have a negative impact on their quality of life (QOL) and mental health.

settingThis study enrolled PWH at the end of life (EOL) who were actively engaged in cure-related research in Southern California, United States. EOL was defined as having a prognosis of 6 months or less to live. We examined the relationship between QOL, mental health, and research participation.

methodsStructured assessments were used to collect comprehensive data on QOL and mental health.

resultsFrom 2017 to 2023, 35 PWH in their final stages of life who were actively engaged in cure-related research were enrolled. Their median age was 62.7 years, and most were White or otherwise non-Hispanic/non-Latino (90.6%), and male (86.7%). Changes in QOL and the presence of neurologic and psychiatric conditions, with a focus on depression and anxiety, were the primary outcomes assessed in this study. Participants had stable QOL scores throughout the study. There was an inverse relationship between QOL and Beck Depression Inventory scores, with higher mean QOL scores being associated with lower mean Beck Depression Inventory scores ( P < 0.001).

conclusionsQOL remained stable among PWH who participate in cure-related research at EOL. The inverse relationship between QOL and depressive symptoms suggests that participation in cure-related research may improve QOL or reduce depressive symptoms in this population. Future interventions should look into ways to improve the well-being of PWH at EOL through research and customized mental health interventions.

Indexed as

HIV InfectionsQuality of LifeAdultAgedAnxietyCaliforniaCohort StudiesDepressionFemaleHumansMaleMental HealthMiddle AgedTerminal Care

Identifiers

PMID39361015
PMCPMC11623374

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.